Status:
COMPLETED
Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy
Lead Sponsor:
Cosmo Technologies Ltd
Conditions:
Polyp and Adenoma Detection During Colonoscopy
Eligibility:
All Genders
18+ years
Brief Summary
Polyp detection rate in colonoscopy following oral administration of MMX methylene blue tablets
Detailed Description
Polyp detection rate in colonoscopy following oral administration of methylene blue MMX modified release tablets in subjects undergoing colonoscopy as outpatients.
Eligibility Criteria
Inclusion
- Patients scheduled for screening or surveillance colonoscopy. Written informed consent.Practising reliable contraception or sterile.Ability to understand and comply with the protocol.
Exclusion
- Pregnancy or lactation known or suspected hypersensitivity GI obstruction or perforation serious cardiovascular, renal or hepatic disease. reduced prothrombin time,elevated serum creatinine.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT01520337
Start Date
January 1 2012
End Date
October 1 2013
Last Update
February 11 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.